Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Cerebrospinal Fluid alpha-Synuclein Does Not Discriminate Between Dementia Disorders.

Autor: Spies PE, Melis RJ, Sjögren MJ, Rikkert MG, Verbeek MM

Publikováno v: Journal of Alzheimer's Disease; 2009, Vol. 16 Issue 2, p363-369, 7p

Protein misfolding, ER stress and chaperones: an approach to develop chaperone-based therapeutics for Alzheimer's disease.

Autor: Singh, Rimaljot¹ (AUTHOR), Kaur, Navpreet¹ (AUTHOR), Dhingra, Neelima² (AUTHOR), Kaur, Tanzeer¹ (AUTHOR)

Publikováno v: International Journal of Neuroscience. Jul2023, Vol. 133 Issue 7, p714-734. 21p.

Cerebrospinal Fluid Biomarkers in Diagnosing Alzheimer's Disease in Clinical Practice: An Illustration with 3 Case Reports.

Autor: Slats D; Department of Geriatric Medicine, Radboud University Nijmegen Medical Centre, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands., Spies PE, Sjögren MJ, Verhey FR, Verbeek MM, Olde Rikkert MG

Publikováno v: Case reports in neurology [Case Rep Neurol] 2010 Feb 24; Vol. 2 (1), pp. 5-11. Date of Electronic Publication: 2010 Feb 24.

Small heat shock proteins Hsp27 or alphaB-crystallin and the protein components of neurofibrillary tangles: tau and neurofilaments.

Autor: Björkdahl C; Karolinska Institutet, Department of Neurobiology, Care Sciences and Society, KI-Alzheimer's Disease Research Center, Novum, Huddinge, Sweden., Sjögren MJ, Zhou X, Concha H, Avila J, Winblad B, Pei JJ

Publikováno v: Journal of neuroscience research [J Neurosci Res] 2008 May 01; Vol. 86 (6), pp. 1343-52.